Data / Drug companies / Hetero Labs Limited
Hetero Labs Limited: 164 products in the FDA NDC directory, labeler code 68554
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hetero Labs Limited (labeler code 68554) lists 164 products in the FDA National Drug Code Directory. By type: 164 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 10, 2025.
The request: Watch Hetero Labs Limited (FDA labeler code 68554): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68554
- Products in commercial distribution
- 164
- Packages
- 164
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 15, 1953
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 164 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 164 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 164 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Zanubrutinib | 68554-0185 | Powder | Bulk ingredients | June 10, 2025 |
| Ezetimibe (form-b) | 68554-0180 | Powder | Bulk ingredients | May 1, 2025 |
| Bosutinib | 68554-0161 | Powder | Bulk ingredients | September 26, 2023 |
| Pirtobrutinib | 68554-0189 | Powder | Bulk ingredients | January 27, 2023 |
| Lenacapavir | 68554-0182 | Powder | Bulk ingredients | December 22, 2022 |
| Lenacapavir spray-dried dispersion | 68554-0176 | Powder | Bulk ingredients | December 22, 2022 |
| Asciminib hydrochloride premix | 68554-0181 | Powder | Bulk ingredients | October 29, 2021 |
| Avacopan | 68554-0175 | Powder | Bulk ingredients | October 7, 2021 |
| Belzutifan premix | 68554-0179 | Powder | Bulk ingredients | August 13, 2021 |
| Belumosudil mesylate | 68554-0172 | Powder | Bulk ingredients | July 16, 2021 |
| Velpatasvir | 68554-0188 | Powder | Bulk ingredients | June 10, 2021 |
| Sotorasib | 68554-0171 | Powder | Bulk ingredients | May 28, 2021 |
| Trilaciclib dihydrochloride dihydrate | 68554-0166 | Powder | Bulk ingredients | February 12, 2021 |
| Vericiguat | 68554-0187 | Powder | Bulk ingredients | January 19, 2021 |
| Vericiguat | 68554-0164 | Powder | Bulk ingredients | January 19, 2021 |
| Relugolix (form-i) | 68554-0165 | Powder | Bulk ingredients | December 18, 2020 |
| Berotralstat dihydrochloride | 68554-0167 | Powder | Bulk ingredients | December 3, 2020 |
| Opicapone | 68554-0174 | Powder | Bulk ingredients | April 24, 2020 |
| Rimegepant hemisulfate sesquihydrate | 68554-0184 | Powder | Bulk ingredients | February 27, 2020 |
| Darunavir | 68554-0114 | Powder | Bulk ingredients | January 1, 2020 |
| Carfilzomib | 68554-0163 | Powder | Bulk ingredients | September 9, 2019 |
| Darolutamide premix | 68554-0140 | Powder | Bulk ingredients | July 30, 2019 |
| Doravirine | 68554-0133 | Powder | Bulk ingredients | August 30, 2018 |
| Doravirine | 68554-0132 | Powder | Bulk ingredients | August 30, 2018 |
| Elagolix sodium | 68554-0155 | Powder | Bulk ingredients | July 23, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.